Callan Family Office’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Sell
78,127
-2,450
-3% -$398K 0.26% 77
2025
Q4
$15.7M Buy
80,577
+23,353
+41% +$5.56M 0.34% 52
2025
Q3
$16.1M Buy
57,224
+13,318
+30% +$3.39M 0.51% 33
2025
Q2
$9.6M Buy
43,906
+21,247
+94% +$3.43M 0.3% 65
2025
Q1
$3.17M Sell
22,659
-2,834
-11% -$461K 0.24% 92
2024
Q4
$4.25M Buy
25,493
+20,984
+465% +$3.73M 0.27% 70
2024
Q3
$768K Buy
4,509
+1,250
+38% +$181K 0.13% 81
2024
Q2
$460K Buy
3,259
+597
+22% +$74.1K 0.09% 92
2024
Q1
$334K Sell
2,662
-83
-3% -$9.5K 0.08% 73
2023
Q4
$289K Buy
2,745
+83
+3% +$9.06K 0.07% 78
2023
Q3
$282K Sell
2,662
-242
-8% -$28K 0.08% 73
2023
Q2
$346K Sell
2,904
-17
-0.6% -$1.76K 0.09% 80
2023
Q1
$271K Buy
+2,921
New +$256K 0.07% 137

Other funds holding ORCL

Callan Family Office's ORCL Position: Q1 2026 in Review

Callan Family Office reduced its Oracle (ORCL) stake by 3% in Q1 2026, selling an estimated $398K and leaving 78,127 shares worth $11.5M. The position accounts for 0.26% of the portfolio, ranked #77.

Callan Family Office first reported a position in ORCL in Q1 2023 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Callan Family Office held 78,127 shares of Oracle worth $11.5M as of Q1 2026.
  • Callan Family Office sold 2,450 Oracle shares in Q1 2026, an estimated $398K.
  • Oracle made up 0.26% of Callan Family Office's portfolio in Q1 2026, its #77 holding.
  • Callan Family Office first reported a position in Oracle in Q1 2023 and has held it in 13 quarters since.
  • Callan Family Office's Oracle position peaked at $16.1M in Q3 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.